# Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lipidomics-reveals-immune-related-adverse-events-in-nsclc-patients-receiving/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jia Yu,Fen Xiong,Yingruo Xu,Hanyan Xu,Xi Zhang,Hongchang Gao,Yuping Li |
| Citations | 19 |
| DOI | 10.1016/j.intimp.2023.111412 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4390445320 |
| PMID | 38160567 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Hanyan Xu](https://scholariq.org/researchers/hanyan-xu/)

## Paper journal

- [International Immunopharmacology](https://scholariq.org/journals/international-immunopharmacology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.